Milrinone
Back to searchMolecule Structure
Scientific Name
Milrinone
Description of the Drug
Milrinone is a PDE-III inhibitor with inotropic, lusitropic, and vasodilatory properties used for the short-term treatment of acute decompensated heart failure.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00235
http://www.drugbank.ca/drugs/DB00235
Brand Name(s)
Primacor
Company Owner(s)
Woodward Pharma Services Llc, Fresenius Kabi Usa Llc, West-Ward Pharmaceuticals International Ltd, Hospira Inc, Hikma Farmaceutica (Portugal) Sa, Caplin Steriles Ltd, Gland Pharma Ltd, Hikma Pharmaceuticals Usa Inc, Eugia Pharma Specialities Ltd, B Braun Medical Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Phosphodiesterase 3A | SINGLE PROTEIN | INHIBITOR | CHEMBL241 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL36947 | |
PharmGKB | PA164749171 | |
Human Metabolome Database | HMDB0014380 | |
DrugBank | DB00235 | |
PubChem: Thomson Pharma | 14773322 | 14797712 |
PubChem | 4197 | |
Mcule | MCULE-8377851655 | |
LINCS | LSM-3493 | |
Nikkaji | J23.655A | |
PDBe | MIL | |
BindingDB | 15296 | |
EPA CompTox Dashboard | DTXSID5023324 | |
DrugCentral | 1809 | |
Brenda | 3352 | |
Guide to Pharmacology | 5225 | |
rxnorm | MILRINONE LACTATE | MILRINONE |
PubChem: Drugs of the Future | 12013065 | |
KEGG Ligand | C07224 | |
ChEBI | 50693 | |
ZINC | ZINC000009224016 |